IL6 and major depressive disorder: The neuroinflammatory hypothesis proposes that elevated levels of peripheral cytokines such as interleukin 6 (IL-6) cross the blood-brain barrier and induce changes in brain structure and function that may contribute to the generation of negative, depressive, and cognitive symptoms in individuals with schizophrenia and MDD (26,27).